# FDA Inspection 984370 - GlaxoSmithKline Research & Development Limited - June 24, 2016

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-research-development-limited/ced7207d-c78d-49ee-9fc7-34b9297a7995
Source feed: FDA_Inspections

> FDA Inspection 984370 for GlaxoSmithKline Research & Development Limited on June 24, 2016. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 984370
- Company Name: GlaxoSmithKline Research & Development Limited
- Inspection Date: 2016-06-24
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1158637 - 2017-05-16](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-research-development-limited/9624d81a-fb84-4897-ad1d-ae8d8d05c105)
- [FDA Inspection 802584 - 2012-10-11](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-research-development-limited/13eb5671-98f2-4743-8c02-2b46e362846a)
- [FDA Inspection 643994 - 2009-12-17](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-research-development-limited/96ec7247-ed53-458b-a3ec-3d73151a6d35)

Company: https://www.keypedia.com/companies/glaxosmithkline-research-development-limited/900caf13-e96b-46b5-8205-2a054736b8ef

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c